Skip to main content

Insights

Clinical Connection

Your trusted source for clinical insights into the trends shaping the workers' compensation and auto no-fault industries.

Popular content

Clinical services

Hikma Launches Opioid Pain Alternative | Clinical Connection

Clinical update

Hikma launches brand alternative to opioid pain reliever Nucynta®

On February 25, 2026, Hikma Pharmaceuticals USA Inc. (Hikma) announced the launch of tapentadol immediate release (IR) tablets, a brand alternative to Collegium’s opioid pain reliever Nucynta®.

Surgical Bundle Drives Improvements in Worker Recovery

Article

Surgical bundle drives dramatic improvements in worker recovery

The innovative Optum–MinWorx surgical program dramatically reduces total claim costs and claim duration.

FDA requires opioid analgesic labeling changes | Clinical Connection

Clinical update

FDA requires opioid analgesic labeling changes

In July 2025, the FDA issued a safety alert regarding risks associated with long-term use of opioid analgesics.

New Migraine Med Available: Symbravo | Clinical Connection

Clinical update

New migraine medication Symbravo approved by FDA

In January 2025, Axsome Therapeutics announced FDA approval of Symbravo for treatment of acute migraine.

Caring for Workers Affected by Climate Change

White paper

Caring for workers affected by climate change

Climate change poses significant health risks for workers; our programs work together to address their needs.

Obesity in the Workforce and GLP-1 Medications

White paper

Obesity in the workforce and GLP-1 medications

Our clinical and policy experts can help you navigate the evolving landscape of GLP-1 medications.